CATIONIC LIPID-BASED GENE DELIVERY SYSTEMS - PHARMACEUTICAL PERSPECTIVES

Citation
Ri. Mahato et al., CATIONIC LIPID-BASED GENE DELIVERY SYSTEMS - PHARMACEUTICAL PERSPECTIVES, Pharmaceutical research, 14(7), 1997, pp. 853-859
Citations number
54
Categorie Soggetti
Pharmacology & Pharmacy",Chemistry
Journal title
ISSN journal
07248741
Volume
14
Issue
7
Year of publication
1997
Pages
853 - 859
Database
ISI
SICI code
0724-8741(1997)14:7<853:CLGDS->2.0.ZU;2-T
Abstract
Gene delivery systems are designed to control the location of administ ered therapeutic genes within a patient's body. Successful in vivo gen e transfer may require (i) the condensation of plasmid and its protect ion from nuclease degradation, (ii) cellular interaction and internali zation of condensed plasmid, (iii) escape of plasmid from endosomes (i f endocytosis is involved), and (iv) plasmid entry into cell nuclei. E xpression plasmids encoding a therapeutic protein can be, for instance , complexed with cationic liposomes or micelles in order to achieve ef fective in vivo gene transfer. A thorough knowledge of pharmaceutics a nd drug delivery, bio-engineering, as well as cell and molecular biolo gy is required to design optimal systems for gene therapy. This mini-r eview provides a critical discussion on cationic lipid-based gene deli very systems and their possible uses as pharmaceuticals.